The novel FSMW is also making use of trapping epithelial-derived tumor cells with a high-affinity antibody directed to EpCAM but other cell surface-directed antibodies can be easily covalently attached to the hydrogel of the FSMW, alone or in combination with EpCAM-directed antibodies. Here, EPCAM is linked to neoplasm.